Avadel Pharmaceuticals PLC Earnings

The next earnings date for Avadel Pharmaceuticals PLC is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Avadel Pharmaceuticals PLC Earnings

Report DateEstimated Earnings Per Share
11/05/2025$0.08

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Avadel Pharmaceuticals PLC Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$0.10216.46%
05/06/2025Before Market$-0.0528.57%
03/03/2025---$-0.05---
11/06/2024Before Market$-0.0345.40%
08/08/2024Before Market$-0.1412.50%
05/08/2024Before Market$-0.30-42.86%
02/29/2024After Market$-0.29-11.54%
11/08/2023Before Market$-0.41-10.81%
08/09/2023Before Market$-0.83-118.42%
05/04/2023After Market$-0.48-26.32%
03/29/2023After Market$-0.46-70.37%
11/09/2022Before Market$-0.33-32.00%
08/09/2022Before Market$-1.01-146.34%
05/09/2022Before Market$-0.45-4.65%
03/17/2022Before Market$-0.387.32%
11/08/2021Before Market$-0.380.00%
08/09/2021Before Market$-0.33-6.45%
05/10/2021Before Market$-0.2328.13%
03/09/2021Before Market$-0.1929.63%
11/09/2020Before Market$-0.2020.00%
08/10/2020Before Market$-0.15-50.00%
05/11/2020Before Market$-0.0291.67%
03/12/2020Before Market$-0.0770.83%
11/12/2019Before Market$-0.2411.11%
08/09/2019Before Market$-0.2320.69%
05/08/2019Before Market$-0.3528.57%
03/15/2019Before Market$0.06102.56%
11/05/2018Before Market$-0.43-2.38%
08/07/2018Before Market$-0.0970.97%
05/02/2018Before Market$-0.32-18.52%
03/08/2018Before Market$-0.1551.61%
11/08/2017Before Market$0.522,700.00%
08/08/2017Before Market$0.681,600.00%
05/09/2017Before Market$0.646,500.00%
03/07/2017Before Market$0.26189.66%
11/07/2016Before Market$-0.54-134.78%
08/08/2016Before Market$-0.48-900.00%
05/09/2016Before Market$-0.15-207.14%
03/10/2016Before Market$1.751,844.44%
11/12/2015Before Market$-0.73-417.39%
07/30/2015Before Market$-0.43-207.50%
05/15/2015Before Market$0.27-12.90%
03/19/2015Before Market$-0.69-305.88%
10/31/2014Before Market$-0.26-116.67%
07/29/2014---$-0.13-44.44%
05/12/2014---$-0.60-300.00%
03/06/2014---$0.20225.00%
10/31/2013---$-0.25-25.00%
07/29/2013---$-1.21-348.15%
05/07/2013---$-0.35-6.06%
02/28/2013---$0.46342.11%
11/05/2012---$-0.26-36.84%
07/25/2012---$0.25412.50%
05/07/2012---$-0.19-171.43%
03/14/2012---$-0.08-180.00%
11/02/2011---$0.07177.78%
07/25/2011---$-0.14-55.56%
05/09/2011---$-0.20-81.82%
03/03/2011---$0.11120.00%
11/04/2010---$-0.14---
07/28/2010---$-0.18-260.00%
05/05/2010---$-0.17-30.77%
03/08/2010---$-0.23-130.00%
11/16/2009---$-0.14-55.56%
08/05/2009---$-0.15-50.00%
05/11/2009---$0.05135.71%
03/04/2009---$-0.11-450.00%
11/03/2008---$-0.1041.18%
08/06/2008---$-0.1444.00%
05/13/2008---$-0.1548.28%
03/03/2008---$-0.2330.30%
10/30/2007---$-0.387.32%
08/01/2007---$-0.57-103.57%
05/07/2007---$-0.38-15.15%
03/07/2007---$-0.2532.43%
11/01/2006---$-0.43-13.16%
07/31/2006---$-0.40-21.21%
05/03/2006---$-0.41-32.26%
03/07/2006---$-0.2817.65%
10/26/2005---$-0.50-35.14%
07/27/2005---$-0.41-5.13%
05/05/2005---$0.01133.33%
03/11/2005---$0.28-9.68%
10/28/2004---$0.129.09%
07/29/2004---$-0.07-200.00%
04/29/2004---$0.18500.00%
03/11/2004---$0.08100.00%
10/30/2003---$-0.11-320.00%
07/30/2003---$-0.10-600.00%
04/30/2003---$-0.10-433.33%
02/23/1999---$-0.12-20.00%
10/27/1998---$-0.17-30.77%
07/31/1998---$-0.140.00%
03/17/1998---$0100.00%
07/31/1997---$-0.228.33%
03/26/1997---$-0.1516.67%

More About Avadel Pharmaceuticals PLC

Country
USA
Full Time Employees
188

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.

Avadel Pharmaceuticals PLC Earnings” Can Refer to the Avadel Pharmaceuticals PLC Earnings Date

Some people say “Avadel Pharmaceuticals PLC earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Avadel Pharmaceuticals PLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Avadel Pharmaceuticals PLC Stock on the Earnings Date

If you own Avadel Pharmaceuticals PLC stock (AVDL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Avadel Pharmaceuticals PLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Avadel Pharmaceuticals PLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Avadel Pharmaceuticals PLC Earnings

You can contact us any time if you would like to ask questions about Avadel Pharmaceuticals PLC earnings or anything else related to the stock market.